SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-203119
Filing Date
2018-06-26
Accepted
2018-06-26 08:13:27
Documents
43
Period of Report
2018-06-26
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d429360d8k.htm 8-K 15842
2 EX-99.1 d429360dex991.htm EX-99.1 36591
3 EX-99.2 d429360dex992.htm EX-99.2 14963
4 GRAPHIC g429360ex99_1s10g1.jpg GRAPHIC 206987
5 GRAPHIC g429360ex99_1s11g1.jpg GRAPHIC 173213
6 GRAPHIC g429360ex99_1s12g1.jpg GRAPHIC 111123
7 GRAPHIC g429360ex99_1s13g1.jpg GRAPHIC 368328
8 GRAPHIC g429360ex99_1s14g1.jpg GRAPHIC 335042
9 GRAPHIC g429360ex99_1s15g1.jpg GRAPHIC 359435
10 GRAPHIC g429360ex99_1s16g1.jpg GRAPHIC 361961
11 GRAPHIC g429360ex99_1s17g1.jpg GRAPHIC 245003
12 GRAPHIC g429360ex99_1s18g1.jpg GRAPHIC 340352
13 GRAPHIC g429360ex99_1s19g1.jpg GRAPHIC 181377
14 GRAPHIC g429360ex99_1s1g1.jpg GRAPHIC 114009
15 GRAPHIC g429360ex99_1s20g1.jpg GRAPHIC 101140
16 GRAPHIC g429360ex99_1s21g1.jpg GRAPHIC 280628
17 GRAPHIC g429360ex99_1s22g1.jpg GRAPHIC 279145
18 GRAPHIC g429360ex99_1s23g1.jpg GRAPHIC 242503
19 GRAPHIC g429360ex99_1s24g1.jpg GRAPHIC 163125
20 GRAPHIC g429360ex99_1s25g1.jpg GRAPHIC 118698
21 GRAPHIC g429360ex99_1s26g1.jpg GRAPHIC 271457
22 GRAPHIC g429360ex99_1s27g1.jpg GRAPHIC 307579
23 GRAPHIC g429360ex99_1s28g1.jpg GRAPHIC 332649
24 GRAPHIC g429360ex99_1s29g1.jpg GRAPHIC 245453
25 GRAPHIC g429360ex99_1s2g1.jpg GRAPHIC 569349
26 GRAPHIC g429360ex99_1s30g1.jpg GRAPHIC 168719
27 GRAPHIC g429360ex99_1s31g1.jpg GRAPHIC 388187
28 GRAPHIC g429360ex99_1s32g1.jpg GRAPHIC 294416
29 GRAPHIC g429360ex99_1s33g1.jpg GRAPHIC 226893
30 GRAPHIC g429360ex99_1s34g1.jpg GRAPHIC 205286
31 GRAPHIC g429360ex99_1s35g1.jpg GRAPHIC 80386
32 GRAPHIC g429360ex99_1s36g1.jpg GRAPHIC 237487
33 GRAPHIC g429360ex99_1s37g1.jpg GRAPHIC 108074
34 GRAPHIC g429360ex99_1s38g1.jpg GRAPHIC 434004
35 GRAPHIC g429360ex99_1s39g1.jpg GRAPHIC 306952
36 GRAPHIC g429360ex99_1s3g1.jpg GRAPHIC 266578
37 GRAPHIC g429360ex99_1s40g1.jpg GRAPHIC 325548
38 GRAPHIC g429360ex99_1s4g1.jpg GRAPHIC 323252
39 GRAPHIC g429360ex99_1s5g1.jpg GRAPHIC 335916
40 GRAPHIC g429360ex99_1s6g1.jpg GRAPHIC 289380
41 GRAPHIC g429360ex99_1s7g1.jpg GRAPHIC 433766
42 GRAPHIC g429360ex99_1s8g1.jpg GRAPHIC 107925
43 GRAPHIC g429360ex99_1s9g1.jpg GRAPHIC 235164
  Complete submission text file 0001193125-18-203119.txt   14501958
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 18918296
SIC: 2834 Pharmaceutical Preparations